Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Diabetic Ulcers Treatment Market
Diabetic Ulcers Treatment Market Share
- Report ID: GMI6078
- Published Date: Jun 2023
- Report Format: PDF
Diabetic Ulcers Treatment Market Share
Major players operating in diabetic ulcers treatment industry include
- B. Braun Melsungen AG
- Smith & Nephew, Inc.
- Organogenesis Holdings Inc.
- Derma Sciences Inc.
- Integra LifeSciences
- Hill Rom Holdings Inc.
- Mölnlycke Health Care AB
- Coloplast Corp
- Cardinal Health
- ConvaTec Group Plc
- Tissue Regenix
- 3M Healthcare
- Medline Industries, Inc.
These leaders majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Frequently Asked Questions (FAQ) :
The market size of diabetic ulcers treatment reached USD 9.3 billion in 2022 and will grow at over CAGR 5.8% CAGR from 2023 to 2032 attributed to the rise in the diabetic population continues.
The foot ulcer segment dominated the diabetic ulcers treatment market in 2022 with a industry share of 88.8%, owing to high incidence of diabetic foot ulcers amongst diabetic patients.
North America diabetic ulcers treatment industry accounted for over 38.3% revenue share in 2022 and will continue to grow over 2023-2032, due to rising diabetes rate in the region due to factors such as sedentary lifestyles, unhealthy eating habits, and an aging population.
B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis Holdings Inc., Derma Sciences Inc., Integra LifeSciences, Hill Rom Holdings Inc., M
Diabetic Ulcers Treatment Market Scope
×
Get a free sample of
Diabetic Ulcers Treatment Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below